
E. coli Gyrase
Click on the product headings below to view details and order online.
E. coli Gyrase

DNA gyrase is a bacterial type II topisomerase which can introduce negative supercoils into DNA. It is a target for both quinolone and coumarin drugs and can be used for screening potential antibacterial compounds. It is prepared from the over producing strains JMtacA and JMtacB1 and is supplied as an A2B2 complex.
Store at -80°C.
All enzyme is supplied with 5X concentrated Assay Buffer and Dilution Buffer which are also available separately. 1 U of gyrase will supercoil 0.5 µg relaxed pBR322 DNA in 30 minutes at 37°C.
See technical documents below for more detailed information and lot specific activities.
Technical Documents
E. coli Gyrase Supercoiling Assay Kits

Kits are available containing everything required to perform supercoiling reactions and to test inhibitors. They contain the enzyme, relaxed DNA substrate and the Assay and Dilution buffers.
Technical Documents
E. coli Gyrase Cleavage Assay Kits

Some drugs interrupt the DNA breakage-reunion step of the gyrase reaction. This leads to cell death and it is the mechanism behind the action of the quinolones such as nalidixic acid and ciprofloxacin. Cleavage assays are particularly useful in determining if a potential drug acts by this mechanism.
These kits are designed specifically for cleavage reactions. They contain the supercoiled pBR322 DNA substrate and the Assay and Dilution buffers required for DNA cleavage reactions in addition to the enzyme and linearised pBR322 marker.
Cleavage specific enzyme available separately on request.
Technical Documents
E. coli Gyrase Assay Kits for Cell Extracts

These kits are designed for assaying cell extracts containing E. coli gyrase and partially purified fractions and contain relaxed DNA substrate, Assay buffer, Dilution buffer and control supercoiled DNA.
Technical Documents
E. coli Gyrase ATPase Kits

These kits can be used to test the effects of potential ATPase inhibitors. For example, the coumarin drugs such as novobiocin inhibit the action of DNA gyrase by competitively inhibiting the hydrolysis of ATP thus preventing supercoiling.
These assays are microtitre plate-based and thus large numbers of compounds can be screened in a relatively short period of time. They also continuous assays which can provide more information than an end point assay.
Technical Documents
High / Medium-Throughput Assay Kit - E. coli Gyrase

The kit is supplied with sufficient E. coli gyrase enzyme, plasmid DNA substrate, buffers and other assay components for 100 assays. The enzyme is supplied at a concentration of 5 U/μl in Dilution Buffer. The kit is also supplied with sufficient wash buffers for one 96-well plate. These buffers are supplied as 20X concentrates and must be diluted with ultra pure water prior to use.
More information about this assay can be found on the "Services" page under "High/Medium Throughput Assay".
Kit issued with limited licence for individual use only.
Patent held by Inspiralis Ltd., Norwich, Norfolk, UK. (Patent No. GB0424953.8, US7838230)
Technical Documents
References
- Hallett, P., Grimshaw, A.J., Wigley, D.B. and Maxwell, A. (1990) Cloning of the DNA gyrase genes under tac promoter control: overproduction of the gyrase A and B proteins. Gene 93: 139-142
- Maxwell, A., Burton, N.P. and O"Hagan, N. (2006) High-throughput assays for DNA gyrase and other topoisomerases. Nucleic Acid Res. 34 (15), e104
ebiomall.com






>
>
>
>
>
>
>
>
>
>
>
>
大家好,有几个设计的药物分子需要测试活性,不知道谁能提供下能做相关测试服务的机构或个人信息不?非常感谢!
肌酸激酶有四种同功酶形式:肌肉型(MM)、脑型(BB)、杂化型(MB)和线粒体型(MiMi)。MM型主要存在于各种肌肉细胞中,BB型主要存在于脑细胞中,MB型主要存在于心肌细胞中,MiMi型主要存在于心肌和骨骼肌线粒体中。肌肉型肌酸激酶分子是由两个相同的亚基组成的二聚体。根据目前已经测定的兔、人、鸡、鼠肌酸激酶的一级结构[3-6],M型亚基由387个氨基酸残基组成,质量为43 KDa左右,分子内有8个巯基,但无二硫键。大熊猫肌肉型肌酸激酶也是二聚体酶,每个亚基由376个氨基酸残基组成,分子量为42 KDa[7]。向左转|向右转
磷酸肌酸激酶(CPK),主要存在于骨骼肌和心肌,在脑组织中也存在,是参与体内的能量代谢的一种酶。在临床上主要用于诊断心肌梗塞。心肌梗塞患者发病后2-4小时,血液中此酶活动即开始升高。比血清中谷草转酸酶和乳酸脱氢酶的活力变化都出现得早。
临床意义:
(1)心肌梗塞后,CPK较谷草转氨酶和乳酸脱氢酶特异性高,但持续时间短,2-4天恢复正常。
(2)病毒性心肌炎,CPK也可升高,对诊断及预后有参考价值。
(3)进行性肌营养不良、多发性肌炎以及肌肉损伤时CPK也可升高。
(4)严重的心绞痛、心包炎、房颤、脑血管意外、脑膜炎以及心脏手术等,CPK可见升高。
1、纳豆激酶是在纳豆发酵过程中由纳豆枯草杆菌(Bacillus subtilisl natto)产生的一种丝氨酸蛋白酶(单链多肽酶),分子量为27728道尔顿。
2、纳豆激酶在温度超过80℃时迅速变性失活,但反复冻融对其影响不大。
3、纳豆激酶在PH值从7升至12时,10min内稳定;PH值低于5时,迅速变性失活。胃酸环境中的PH值只有1.2到2之间,纳豆激酶根本无法通过。
4、纳豆激酶与粘性物质混合后,在PH值2-3的酸性环境中,还能保持不超过7.5%的活性。
5、纳豆激酶是大分子的单链多肽酶,可被肠道消化液(糜蛋白酶、胰蛋白酶、小肠液等)分解成氨基酸片段或分子量更小的肽链。
纳豆一词源于日本,是日本发酵食品,源自中国的咸豆豉,但并非中国豆豉,而是由黄豆通过纳豆菌(枯草杆菌)发酵制成豆制品,具有黏性,气味较臭,味道较甜,不仅保有黄豆的营养价值、富含维生素K2、提高蛋白质的消化吸收率,更重要的是发酵过程产生了多种生理活性物质,具有溶解体内纤维蛋白及其他调节生理机能的保健作用。

